Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Window of Opportunity Opens in Stroke

This article was originally published in Start Up

Executive Summary

The field of stroke moves slowly; 17 years elapsed between the introduction of the thrombolytic drug tPA, the first FDA-approved intervention for acute ischemic stroke, and the clot retrieving device from Concentric Medical. The goal of these rdr rmost therapies is to quickly and safely achieve revascularization of the source of the blockage that caused the stroke. The problem has been, and continues to be, the very narrow therapeutic window of opportunity for stroke victims; that is the short time during which recovery is possible. Concentric Medical and Penumbra have both succeeded in widening the treatment window, from the three hour cut-off for tPA to eight hours. Others will follow. According to US Markets for Stroke Management Products, a report just issued by the FDC-Windhover division of Elsevier, this market will rapidly over the next few years because clinicians trained on first-generation devices are now prepared for improved neurointerventional technologies. The report estimates that cerebral revascularization and reperfusion device sales will grow at a compound annual rate of 33.4% through the year 2012.

Related Content

Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts